TaiGen Biopharmaceuticals Holdings Limited(TW:4157)
NT$7.91-0.58 (-6.83%)
TW:4157
TaiGen Biopharmaceuticals Holdings Limited earnings date
NT$7.91
At close:-0.58 (-6.83%)
Want to see TW:4157 full AI Analyst Report?
TaiGen Biopharmaceuticals Holdings Limited (4157) Q2 2025 Earnings Report
TW:4157 Q2 2025 EPS Results
- Actual EPS
- -TWD 0.17
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- TWD 0.09
TW:4157 Q2 2025 Revenue Results
- Actual Revenue
- TWD 10.70M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -91.19%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/20/2025
- Time
- Before Open
- Conference Call
- Wednesday, August 20, 2025
TW:4157 Upcoming Earnings
TaiGen Biopharmaceuticals Holdings Limited's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
TW:4157 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | ―- | 0.29 | ― | ― |
| Nov 18, 2026 | 2026 (Q3) | ―-0.02 | -0.02 | -15.00% (-0.00) | |
| Aug 26, 2026 | 2026 (Q2) | ―-0.03 | -0.17 | 82.46% (+0.14) | |
| May 12, 2026 | 2026 (Q1) | ―-0.02 | -0.03 | 37.50% (+0.01) | |
| Mar 13, 2026 | 2025 (Q4) | ―0.29 | -0.03 | 947.06% (+0.32) | |
| Nov 13, 2025 | 2025 (Q3) | ―-0.02 | -0.1 | 80.00% (+0.08) | |
| Aug 20, 2025 | 2025 (Q2) | ―-0.17 | 0.09 | -290.00% (-0.26) | |
| May 14, 2025 | 2025 (Q1) | ―-0.03 | -0.01 | -255.56% (-0.02) | |
| Mar 13, 2025 | 2024 (Q4) | ―-0.03 | 0.26 | -113.13% (-0.29) | |
| Nov 13, 2024 | 2024 (Q3) | ―-0.10 | -0.01 | -733.33% (-0.09) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

